Documents published by European Medicines Agency on weight-management medicines, compounding and peptide products. Every link goes to the regulator's own page. Informational only.
Ask TinaTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Positive coverage and opinions: this section collects regulator announcements of approvals and authorizations.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026European Medicines Agency · 2026-06-26First oral GLP-1 treatment for weight managementEuropean Medicines Agency · 2026-05-22Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026European Medicines Agency · 2026-05-22Primary documents from the regulator for your own interpretation. No third-party commentary or opinion pieces.
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and WegovyEuropean Medicines Agency · 2025-06-06EMA concludes review of weight management medicine MysimbaEuropean Medicines Agency · 2025-03-28Ask Tina for links to further coverageTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.